Spyre Therapeutics Inc. (NASDAQ: SYRE)
$30.57
+1.7650 ( +6.13% ) 496.0K
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
Market Data
Open
$30.57
Previous close
$28.80
Volume
496.0K
Market cap
$1.55B
Day range
$28.81 - $31.13
52 week range
$10.42 - $47.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Feb 05, 2024 |
8-k | 8K-related | 20 | Feb 05, 2024 |
4 | Insider transactions | 1 | Feb 05, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
8-k | 8K-related | 12 | Jan 18, 2024 |
4 | Insider transactions | 1 | Dec 29, 2023 |
4 | Insider transactions | 1 | Dec 22, 2023 |
4 | Insider transactions | 1 | Dec 11, 2023 |